Marker Therapeutics files amendment for 1-for-10 reverse stock split and authorized share reduction

Marker Therapeutics, Inc.

Filed Certificate of Amendment on January 26, 2023, effective 5:00 p.m. ET that day.
Reverse stock split combines every 10 shares into 1, with no fractional shares issued.
Authorized shares reduced from 300,000,000 to 30,000,000 at same par value of $0.001.
Common stock will begin trading on Nasdaq Capital Market on a split-adjusted basis on January 27, 2023.
Adjustments made to all outstanding stock options, warrants, and equity compensation reserves.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.